Astrocyte Reactivity: Subtypes, States, and Functions in CNS Innate Immunity.

Mammalian astrocytes respond to diverse reactivity-inducing triggers and produce diverse molecular effectors.A. Astrocyte reactivity can be triggered by a wide variety of molecules that can derive from diverse sources, including any cell type in CNS tissue, as well as from microbial pathogens, circulating inflammatory cells, serum proteins, peripheral metabolic disorders or environmental toxins. B. Reactive astrocytes can exhibit diverse functional responses to these triggers and can elaborate a wide variety of effector molecules that can influence many different cell types in a context-specific manner. BBB blood-brain barrier, bv blood vessel, OPC oligodendrocyte progenitor cell. Protein abbreviations are per international guidelines (https://www.genecards.org/). Small molecule abbreviations: Aβ amyloid beta, Glut glutamate, NE norepinephrine, NO nitric oxide, ROS reactive oxygen species.

Key Figure – Working model of diverse astrocyte responses to CNS disorders.A. In healthy tissue, astrocytes exhibit regional and local heterogeneity in gene expression and function. Diverse starting conditions can influence subsequent reactivity responses. B. Different forms of astrocyte reactivity are triggered by diverse non-cell-autonomous signals emanating from diverse CNS insults. C. Proliferative astrocyte reactivity occurs in response to tissue damage caused e.g. by traumatic or ischemic cell degeneration, blood-brain barrier leak, infection or autoimmune leukocytic inflammation. Newly proliferated astrocytes (red nuclei) form limitans borders that permanently separate and corral areas of damage, inflammation and non-neural scar tissue from adjacent viable neural tissue. D. Non-proliferative astrocyte reactivity can exhibit diverse states with different changes in gene expression and functions that are context dependent as determined by astrocyte starting conditions and incoming reactivity triggers. Non-proliferative reactive astrocytes maintain but modify their interactions with surrounding cells in preserved tissue architecture. E. Non-proliferative astrocyte reactivity can resolve over time if acute triggers recede. F. Astrocyte reactivity can become chronic if triggers persist. G. Chronic astrocyte reactivity can lead to loss- or gain-of-functions resulting in disease states with dysfunctional reactivity that can exacerbate tissue pathologies and worsen disorder outcome. H. Genetic mutations and polymorphisms can lead to cell-autonomous dysfunctions in astrocytes that lead to non-reactive disease states. Such disease states can in the absence of astrocyte reactivity, cause or contribute to tissue dysfunctions that in turn lead to production of astrocyte reactivity triggers. The ensuing dysfunctional astrocyte reactivity exhibits gain- or loss-of-functions that can contribute to further tissue pathology in a vicious cycle. Details and literature references are in the main text.

Astrocytes in healthy human and mouse tissue express multiple DAMP and PAMP receptors.Pink boxes indicate significant receptor gene expression. DAMP and PAMP receptor information taken from reference [90]. CP, caudate putamen, Cx cerebral cortex, Hp hippocampus, Hu, human, Ms mouse, SC spinal cord. Expression data taken from references [34–36, 57] ) and their associated open access databases: a http://www.brainrnaseq.org/ b http://astrocyternaseq.org/ c https://astrocyte.rnaseq.sofroniewlab.neurobio.ucla.edu./addgene?query=Clec9a